Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial

H.C. Toh, M.-H. Yang, H.-M. Wang, C.Y. Hsieh, I. Chitapanarux, K.F. Ho, R.-L. Hong, M.K. Ang, A.D. Colevas, E. Sirachainan, C. Lertbutsayanukul, G.F. Ho, E. Nadler, A. Algazi, P. Lulla, L.J. Wirth, K. Wirasorn, Y.C. Liu, S.F. Ang, S.H.J. Low, L.M. Tho, H.H. Hasbullah, M.K. Brenner, W.-W. Wang, W.S. Ong, S.H. Tan, I. Horak, C. Ding, A. Myo, J. Samol

Open source

DOI: 10.1016/j.annonc.2024.08.2344
Published: 2024-12
Container: Annals of Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.annonc.2024.08.2344,
  title = {Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial},
  author = {H.C. Toh and M.-H. Yang and H.-M. Wang and C.Y. Hsieh and I. Chitapanarux and K.F. Ho and R.-L. Hong and M.K. Ang and A.D. Colevas and E. Sirachainan and C. Lertbutsayanukul and G.F. Ho and E. Nadler and A. Algazi and P. Lulla and L.J. Wirth and K. Wirasorn and Y.C. Liu and S.F. Ang and S.H.J. Low and L.M. Tho and H.H. Hasbullah and M.K. Brenner and W.-W. Wang and W.S. Ong and S.H. Tan and I. Horak and C. Ding and A. Myo and J. Samol},
  year = {2024},
  journal = {Annals of Oncology},
  doi = {10.1016/j.annonc.2024.08.2344},
  url = {https://doi.org/10.1016/j.annonc.2024.08.2344}
}

RIS

TY  - JOUR
TI  - Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
AU  - H.C. Toh
AU  - M.-H. Yang
AU  - H.-M. Wang
AU  - C.Y. Hsieh
AU  - I. Chitapanarux
AU  - K.F. Ho
AU  - R.-L. Hong
AU  - M.K. Ang
AU  - A.D. Colevas
AU  - E. Sirachainan
AU  - C. Lertbutsayanukul
AU  - G.F. Ho
AU  - E. Nadler
AU  - A. Algazi
AU  - P. Lulla
AU  - L.J. Wirth
AU  - K. Wirasorn
AU  - Y.C. Liu
AU  - S.F. Ang
AU  - S.H.J. Low
AU  - L.M. Tho
AU  - H.H. Hasbullah
AU  - M.K. Brenner
AU  - W.-W. Wang
AU  - W.S. Ong
AU  - S.H. Tan
AU  - I. Horak
AU  - C. Ding
AU  - A. Myo
AU  - J. Samol
PY  - 2024
JO  - Annals of Oncology
DO  - 10.1016/j.annonc.2024.08.2344
UR  - https://doi.org/10.1016/j.annonc.2024.08.2344
ER  -

APA

Toh, H., Yang, M., Wang, H., Hsieh, C., Chitapanarux, I., Ho, K., Hong, R., Ang, M., Colevas, A., Sirachainan, E., Lertbutsayanukul, C., Ho, G., Nadler, E., Algazi, A., Lulla, P., Wirth, L., Wirasorn, K., Liu, Y., Ang, S., Low, S., Tho, L., Hasbullah, H., Brenner, M., Wang, W., Ong, W., Tan, S., Horak, I., Ding, C., Myo, A., & Samol, J. (2024). Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial. Annals of Oncology. https://doi.org/10.1016/j.annonc.2024.08.2344

Source records

crossref · retrieved 2026-09-26T12:29:10.936Z